Extracellular Synthesis of Bioactive Silver Nanoparticles Using <i>Brevibacillus</i> sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>

The purpose of current study was the green synthesis of bioactive silver nanoparticles (AgNPs) using <i>Brevibacillus</i> sp. MAHUQ-41 and the exploration of their role in controlling drug-resistant bacterial pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enter...

Full description

Saved in:
Bibliographic Details
Main Author: Md. Amdadul Huq
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Journal of Functional Biomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4983/16/7/241
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849406530423619584
author Md. Amdadul Huq
author_facet Md. Amdadul Huq
author_sort Md. Amdadul Huq
collection DOAJ
description The purpose of current study was the green synthesis of bioactive silver nanoparticles (AgNPs) using <i>Brevibacillus</i> sp. MAHUQ-41 and the exploration of their role in controlling drug-resistant bacterial pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>. The culture supernatant of strain MAHUQ-41 was employed for a simple and eco-friendly synthesis of biofunctional silver nanoparticles (AgNPs). The resulting nanoparticles were analyzed using several techniques, including UV–Visible spectroscopy, XRD, FE-TEM, FTIR, and DLS. The UV–Vis spectral analysis of the AgNPs synthesized via <i>Brevibacillus</i> sp. MAHUQ-41 revealed a prominent absorption peak at 400 nm. FE-TEM results confirmed spherical-shaped 15–60 nm sized nanoparticles. XRD results indicated that the synthesized AgNPs were crystalline in nature. The FTIR spectrum determined various functional groups on the surface of synthesized nanoparticles. Potent antibacterial properties were observed in green-synthesized AgNPs against tested pathogens. The MIC value of extracellular synthesized AgNPs for both pathogenic bacteria was 6.2 µg/mL, and the MBCs were 25.0 µg/mL and 12.5 µg/mL for <i>L. monocytogenes</i> and <i>Y. enterocolitica,</i> respectively. Treatment by synthesized AgNPs resulted in morphological alterations and structural damages in both <i>L. monocytogenes</i> and <i>Y. enterocolitica</i>. These alterations can interfere with regular cellular activities, potentially resulting in cell death. This study is the first to report the antimicrobial properties of silver nanoparticles synthesized using <i>Brevibacillus</i> sp. MAHUQ-41. The findings obtained in the present study supported the role of <i>Brevibacillus</i> sp. MAHUQ-41-mediated synthesized AgNPs in controlling drug-resistant bacterial pathogens <i>L. monocytogenes</i> and <i>Y. enterocolitica</i>.
format Article
id doaj-art-273080cb6d964a02a439eeec049cdc53
institution Kabale University
issn 2079-4983
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Journal of Functional Biomaterials
spelling doaj-art-273080cb6d964a02a439eeec049cdc532025-08-20T03:36:21ZengMDPI AGJournal of Functional Biomaterials2079-49832025-06-0116724110.3390/jfb16070241Extracellular Synthesis of Bioactive Silver Nanoparticles Using <i>Brevibacillus</i> sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>Md. Amdadul Huq0Department of Life Sciences, College of BioNano Technology, Gachon University, Seongnam 13120, Republic of KoreaThe purpose of current study was the green synthesis of bioactive silver nanoparticles (AgNPs) using <i>Brevibacillus</i> sp. MAHUQ-41 and the exploration of their role in controlling drug-resistant bacterial pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>. The culture supernatant of strain MAHUQ-41 was employed for a simple and eco-friendly synthesis of biofunctional silver nanoparticles (AgNPs). The resulting nanoparticles were analyzed using several techniques, including UV–Visible spectroscopy, XRD, FE-TEM, FTIR, and DLS. The UV–Vis spectral analysis of the AgNPs synthesized via <i>Brevibacillus</i> sp. MAHUQ-41 revealed a prominent absorption peak at 400 nm. FE-TEM results confirmed spherical-shaped 15–60 nm sized nanoparticles. XRD results indicated that the synthesized AgNPs were crystalline in nature. The FTIR spectrum determined various functional groups on the surface of synthesized nanoparticles. Potent antibacterial properties were observed in green-synthesized AgNPs against tested pathogens. The MIC value of extracellular synthesized AgNPs for both pathogenic bacteria was 6.2 µg/mL, and the MBCs were 25.0 µg/mL and 12.5 µg/mL for <i>L. monocytogenes</i> and <i>Y. enterocolitica,</i> respectively. Treatment by synthesized AgNPs resulted in morphological alterations and structural damages in both <i>L. monocytogenes</i> and <i>Y. enterocolitica</i>. These alterations can interfere with regular cellular activities, potentially resulting in cell death. This study is the first to report the antimicrobial properties of silver nanoparticles synthesized using <i>Brevibacillus</i> sp. MAHUQ-41. The findings obtained in the present study supported the role of <i>Brevibacillus</i> sp. MAHUQ-41-mediated synthesized AgNPs in controlling drug-resistant bacterial pathogens <i>L. monocytogenes</i> and <i>Y. enterocolitica</i>.https://www.mdpi.com/2079-4983/16/7/241<i>Brevibacillus</i> sp. MAHUQ-41silver nanoparticlesextracellular synthesis<i>Listeria monocytogenes</i><i>Yersinia enterocolitica</i>
spellingShingle Md. Amdadul Huq
Extracellular Synthesis of Bioactive Silver Nanoparticles Using <i>Brevibacillus</i> sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>
Journal of Functional Biomaterials
<i>Brevibacillus</i> sp. MAHUQ-41
silver nanoparticles
extracellular synthesis
<i>Listeria monocytogenes</i>
<i>Yersinia enterocolitica</i>
title Extracellular Synthesis of Bioactive Silver Nanoparticles Using <i>Brevibacillus</i> sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>
title_full Extracellular Synthesis of Bioactive Silver Nanoparticles Using <i>Brevibacillus</i> sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>
title_fullStr Extracellular Synthesis of Bioactive Silver Nanoparticles Using <i>Brevibacillus</i> sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>
title_full_unstemmed Extracellular Synthesis of Bioactive Silver Nanoparticles Using <i>Brevibacillus</i> sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>
title_short Extracellular Synthesis of Bioactive Silver Nanoparticles Using <i>Brevibacillus</i> sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>
title_sort extracellular synthesis of bioactive silver nanoparticles using i brevibacillus i sp mahuq 41 and their potential application against drug resistant bacterial pathogens i listeria monocytogenes i and i yersinia enterocolitica i
topic <i>Brevibacillus</i> sp. MAHUQ-41
silver nanoparticles
extracellular synthesis
<i>Listeria monocytogenes</i>
<i>Yersinia enterocolitica</i>
url https://www.mdpi.com/2079-4983/16/7/241
work_keys_str_mv AT mdamdadulhuq extracellularsynthesisofbioactivesilvernanoparticlesusingibrevibacillusispmahuq41andtheirpotentialapplicationagainstdrugresistantbacterialpathogensilisteriamonocytogenesiandiyersiniaenterocoliticai